PROTAC BRD9 Degrader-7
PROTAC BRD9 Degrader-7 is an orally active, selective BRD9 PROTAC degrader (DC50 = 1.02 nM). PROTAC BRD9 Degrader-7 mediates BRD9 degradation via the ubiquitin-proteasome system. PROTAC BRD9 Degrader-7 exhibits proliferation inhibitory activity in the MV4-11 cells. PROTAC BRD9 Degrader-7 can be used in the research of acute myeloid leukemia and other related malignancies. (Pink: BI 7271: HY-123616, Blue: 5-Aminothalidomide: HY-W023573, Blue + Black: Thalidomide-5-piperazine: HY-W834174, Black: N, N'-Dimethylpiperazine: HY-W539783).
Product Specifications
CAS Number
3056013-04-5
UNSPSC
12352005
Target
Epigenetic Reader Domain; PROTACs
Type
Reference compound
Related Pathways
Epigenetics; PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/protac-brd9-degrader-7.html
Purity
99.29
Solubility
DMSO : 70 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(N(C)C=C1C2=CC(OC)=C(CN3CCN(C4=CC=C5C(C(N(C6C(NC(CC6)=O)=O)C5=O)=O)=C4)CC3)C(OC)=C2)C7=C1C=CC=C7
Molecular Formula
C36H35N5O7
Molecular Weight
649.69
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Badge
Hot
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
BRD9; Cereblon
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
SOX2 (Transcription Factor) (SOX2/1792), Biotin conjugate, 0.1mg/mL
